UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 387

Sortiert nach

118 Delineation of spatial tissue signatures of immunotherapy response groups in non-small cell lung cancer (NSCLC)

Journal for immunotherapy of cancer, 2022, Vol.10 (Suppl 2), p.A130-A130

2022

Link zum Volltext

Verfügbarkeit prüfen

14 - Microenvironment and Lung Cancer

IASLC Thoracic Oncology, 2018, p.121-128.e4

Second Edition, 2018

Link zum Volltext

Verfügbarkeit prüfen

1st ESMO Consensus Conference in lung cancer; Lugano 2010: Small-cell lung cancer

Annals of oncology, 2011-09, Vol.22 (9), p.1973-1980

2011

Link zum Volltext

Verfügbarkeit prüfen

IL - 20 is epigenetically regulated in NSCLC and down regulates the expression of VEGF

European journal of cancer (1990), 2011-08, Vol.47 (12), p.1908-1918

2011

Link zum Volltext

Verfügbarkeit prüfen

IL-23 is pro-proliferative, epigenetically regulated and modulated by chemotherapy in non-small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2013-01, Vol.79 (1), p.83-90

2013

Link zum Volltext

Verfügbarkeit prüfen

IL-23R is Epigenetically Regulated and Modulated by Chemotherapy in Non-Small Cell Lung Cancer

Frontiers in oncology, 2013, Vol.3, p.162

2013

Link zum Volltext

Verfügbarkeit prüfen

43 Highly multiplexed digital spatial profiling of the tumor microenvironment of non-small-cell lung cancer (NSCLC)

Journal for immunotherapy of cancer, 2020-11, Vol.8 (Suppl 3), p.A44-A44

2020

Link zum Volltext

Verfügbarkeit prüfen

62 Tumour necrosis factor-alpha cell signalling events in human bronchoepithelial cells

Lung cancer (Amsterdam, Netherlands), 2003-08, Vol.41, p.S288-S288

2003

Link zum Volltext

Verfügbarkeit prüfen

Abnormal levels of heterogeneous nuclear ribonucleoprotein A2B1 (hnRNPA2B1) in tumour tissue and blood samples from patients diagnosed with lung cancer

Molecular bioSystems, 2015-03, Vol.11 (3), p.743-752

2015

Link zum Volltext

Verfügbarkeit prüfen

Abstract 702: RON receptor tyrosine kinase: A potential therapeutic target in malignant pleural mesothelioma

Cancer research (Chicago, Ill.), 2010-04, Vol.70 (8_Supplement), p.702-702

2010

Link zum Volltext

Verfügbarkeit prüfen

Abstract A45: In depth molecular characterization of novel PI3K-mTOR inhibitor resistant NSCLC cell lines

Molecular cancer therapeutics, 2015-07, Vol.14 (7_Supplement), p.A45-A45

2015

Link zum Volltext

Verfügbarkeit prüfen

Abstract B25: PI3K targeted inhibition in NSCLC: An in vitro evaluation and correlation of mutation status to activated PI3K pathway signaling in NSCLC patients

Molecular cancer therapeutics, 2015-07, Vol.14 (7_Supplement), p.B25-B25

2015

Link zum Volltext

Verfügbarkeit prüfen

Abstract CT077: Nivolumab (nivo) + ipilimumab (ipi) vs platinum-doublet chemotherapy (PT-DC) as first-line (1L) treatment (tx) for advanced non-small cell lung cancer (NSCLC): initial results from CheckMate 227

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.CT077-CT077

2018

Link zum Volltext

Verfügbarkeit prüfen

Abstract CT078: Tumor mutational burden (TMB) as a biomarker for clinical benefit from dual immune checkpoint blockade with nivolumab (nivo) + ipilimumab (ipi) in first-line (1L) non-small cell lung cancer (NSCLC): identification of TMB cutoff from CheckMate 568

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.CT078-CT078

2018

Link zum Volltext

Verfügbarkeit prüfen

Abstract CT117: Evaluation of the effect of crizotinib (CRZ) on the QT interval in patients with ALK-positive non-small cell lung cancer (NSCLC)

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.CT117-CT117

2015

Link zum Volltext

Verfügbarkeit prüfen

Abstract PO-031: Aldolase A (ALDOA) is required for efficient DNA double-strand break (DSB) repair

Clinical cancer research, 2021-04, Vol.27 (8_Supplement), p.PO-031-PO-031

2021

Link zum Volltext

Verfügbarkeit prüfen

Acquired Hemophilia A Secondary to an Immune Checkpoint Inhibitor: A Case Report

JTO clinical and research reports, 2022-11, Vol.3 (11), p.100409, Article 100409

2022

Link zum Volltext

Verfügbarkeit prüfen

Acquired Hemophilia A Secondary to an Immune Checkpoint Inhibitor: A Case Report

JTO clinical and research reports, 2022, Vol.3 (11), p.100409-100409

2022

Link zum Volltext

Verfügbarkeit prüfen

Activation and cleavage of SASH1 by caspase-3 mediates an apoptotic response

Cell death & disease, 2016-11, Vol.7 (11), p.e2469-e2469

2016

Link zum Volltext

Verfügbarkeit prüfen

Activation of NF-κB by Asbestos through EGF-R Signalling in Mesothelial Cells is Important in Cell Survival

The Annals of occupational hygiene, 2002, Vol.46 (suppl-1), p.85-89

2002

Link zum Volltext

Verfügbarkeit prüfen

Activation of p38 MAP kinase by asbestos in rat mesothelial cells is mediated by oxidative stress

American journal of physiology. Lung cellular and molecular physiology, 2004-04, Vol.286 (4), p.859-L865

2004

Link zum Volltext

Verfügbarkeit prüfen

Activation of p38 MAP kinase by asbestos in rat mesothelial cells is mediated by oxidative stress

American journal of physiology. Lung cellular and molecular physiology, 2004-04, Vol.30 (4), p.859-865

2004

Link zum Volltext

Verfügbarkeit prüfen

Adult Asthma Consensus Guidelines update 2003

Canadian respiratory journal, 2004, Vol.11 Suppl A (suppl a), p.9A-18A

2004

Link zum Volltext

Verfügbarkeit prüfen

Advances in the systemic therapy of malignant pleural mesothelioma

Nature clinical practice. Oncology, 2008-03, Vol.5 (3), p.136-147

2008

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 387

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(361)
Mit Volltextzugriff
(372)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(230)
Life Sciences & Biomedicine
(215)
Humans
(194)
Oncology
(154)
Female
(86)
Male
(82)
Middle Aged
(76)
Aged
(71)
Adult
(69)
Lung Cancer
(67)
Lung Neoplasms - Pathology
(57)
Biological And Medical Sciences
(56)
Lung Neoplasms - Drug Therapy
(54)
Chemotherapy
(53)
Medical Sciences
(53)
Tumors
(50)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(44)
Lung Neoplasms - Genetics
(43)
Respiratory System
(41)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(39)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

118 Delineation of spatial tissue signatures of immunotherapy response groups in non-small cell lung cancer (NSCLC)

14 - Microenvironment and Lung Cancer

1st ESMO Consensus Conference in lung cancer; Lugano 2010: Small-cell lung cancer

IL - 20 is epigenetically regulated in NSCLC and down regulates the expression of VEGF

IL-23 is pro-proliferative, epigenetically regulated and modulated by chemotherapy in non-small cell lung cancer

IL-23R is Epigenetically Regulated and Modulated by Chemotherapy in Non-Small Cell Lung Cancer

43 Highly multiplexed digital spatial profiling of the tumor microenvironment of non-small-cell lung cancer (NSCLC)

62 Tumour necrosis factor-alpha cell signalling events in human bronchoepithelial cells

Abnormal levels of heterogeneous nuclear ribonucleoprotein A2B1 (hnRNPA2B1) in tumour tissue and blood samples from patients diagnosed with lung cancer

Abnormal levels of heterogeneous nuclear ribonucleoprotein A2B1 (hnRNPA2B1) in tumour tissue and blood samples from patients diagnosed with lung cancerElectronic supplementary information (ESI) available. See DOI: 10.1039/c4mb00384e

Abstract 702: RON receptor tyrosine kinase: A potential therapeutic target in malignant pleural mesothelioma

Abstract A45: In depth molecular characterization of novel PI3K-mTOR inhibitor resistant NSCLC cell lines

Abstract B25: PI3K targeted inhibition in NSCLC: An in vitro evaluation and correlation of mutation status to activated PI3K pathway signaling in NSCLC patients

Abstract CT077: Nivolumab (nivo) + ipilimumab (ipi) vs platinum-doublet chemotherapy (PT-DC) as first-line (1L) treatment (tx) for advanced non-small cell lung cancer (NSCLC): initial results from CheckMate 227

Abstract CT078: Tumor mutational burden (TMB) as a biomarker for clinical benefit from dual immune checkpoint blockade with nivolumab (nivo) + ipilimumab (ipi) in first-line (1L) non-small cell lung cancer (NSCLC): identification of TMB cutoff from CheckMate 568

Abstract CT117: Evaluation of the effect of crizotinib (CRZ) on the QT interval in patients with ALK-positive non-small cell lung cancer (NSCLC)

Abstract PO-031: Aldolase A (ALDOA) is required for efficient DNA double-strand break (DSB) repair

Acquired Hemophilia A Secondary to an Immune Checkpoint Inhibitor: A Case Report

Acquired Hemophilia A Secondary to an Immune Checkpoint Inhibitor: A Case Report

Activation and cleavage of SASH1 by caspase-3 mediates an apoptotic response

Activation of NF-κB by Asbestos through EGF-R Signalling in Mesothelial Cells is Important in Cell Survival

Activation of p38 MAP kinase by asbestos in rat mesothelial cells is mediated by oxidative stress

Activation of p38 MAP kinase by asbestos in rat mesothelial cells is mediated by oxidative stress

Adult Asthma Consensus Guidelines update 2003

Advances in the systemic therapy of malignant pleural mesothelioma

Suchergebnisse filtern